Background illustration for clinical trials search

Paid Clinical Trials Charleston

Discover 657 paid clinical trials in Charleston, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Charleston SC, Celebration FL, Denver CO, Nashville TN,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase 1, Phase 2, Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Charleston SC, Wilmington NC, Charlotte NC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase 3, Recruiting

T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer

for
Prostate Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: Male

Age: 18+

Code: NCT05586360

Phase 2, Recruiting

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer,
Location: Charleston SC, Greenville SC, Nashville TN, St Louis MO,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18+

Code: NCT07545811

Phase 1, Recruiting

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

for
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC),
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07149207

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

for
Advanced Renal Cell Carcinoma (RCC)
Location: Charleston SC, Myrtle Beach SC, Washington D.C. DC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07293351

Phase 1, Phase 2, Recruiting

Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma

for
Metastatic Pancreatic Adenocarcinoma,
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07076212

Phase 2, Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

for
Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma,
Location: Charleston SC, Greenville SC, Durham NC, Sarasota FL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06084481

Phase 1, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Charleston SC, Myrtle Beach SC, Athens GA, Orlando FL,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting

A Trial of Varenicline for E-cigarette Cessation

for
E-cigarette Use, Vaping, Nicotine Dependence
Location: Charleston SC, New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07040566

Phase 2, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Charleston SC, Jacksonville FL, Greenville SC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase 3, Recruiting

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

for
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT05702853

Phase 1, Phase 2, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Charleston SC, Blacksburg VA, Clermont FL, Tampa FL,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase 2, Recruiting

Phase 2 Study of Fingolimod in Lung Cancers

for
Non Small Cell Lung Cancer, Small-cell Lung Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06424067

Phase 2, Recruiting

StrokeNet Thrombectomy Endovascular Platform

for
Ischemic Stroke
Location: Charleston SC, Charlotte NC, Winston-Salem NC,
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06289985

Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for
Advanced Systemic Mastocytosis (AdvSM),
Location: Charleston SC, Atlanta GA, Toronto, Boston MA,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04996875

Phase 2, Recruiting

Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

for
Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
Location: Charleston SC, Durham NC, Columbus OH, Philadelphia PA,
Sponsor: Ottawa Heart Institute Research Corporation

Sex: All

Age: 18 - 70+

Code: NCT03536312

Recruiting

PULSED AF Post-Approval Study

for
Atrial Fibrillation
Location: Charleston SC, Anderson SC, Durham NC, Atlanta GA,
Sponsor: Medtronic Cardiac Ablation Solutions

Sex: All

Age: 18+

Code: NCT06578104

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Charleston SC, Chapel Hill NC, Durham NC,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06703073

Phase 2, Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Charleston SC, Chapel Hill NC, Durham NC,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701682

Phase 2, Recruiting